Clinical Trials Logo

Supraspinatus Tear clinical trials

View clinical trials related to Supraspinatus Tear.

Filter by:
  • None
  • Page 1

NCT ID: NCT05660031 Recruiting - Supraspinatus Tear Clinical Trials

Treatment of the Biceps With Concomitant Supraspinatus Tears

Start date: June 1, 2021
Phase: N/A
Study type: Interventional

The long head of the biceps (LHB) tendon is thought to be a common source of shoulder pain and dysfunction in patients with rotator cuff pathology. Tenotomy and tenodesis have been shown to produce favourable and comparable results in treating LHB lesions, but a controversy still exists regarding the treatment of choice. Some suggest that tenotomy should be reserved for older, low-demand patients, while tenodesis should be performed in younger patients and those who engage in heavy labor. Proponents of tenotomy suggest that this is a technically easy procedure that leads to easy rehabilitation and fast return to activity with a low complication and reoperation rate. However, those who support LHB tenodesis list good preservation of elbow flexion and supination strength, improvement of functional scores, elimination of pain, and avoidance of cosmetic deformity as benefits of the procedure. Alternatively, the LHB can be maintained in the joint without tenodesis or tenotomy. In fact, it has not been clearly shown that LHB tenodesis or tenotomy leads to improved outcomes compared to leaving the biceps tendon intact.

NCT ID: NCT05590494 Recruiting - Supraspinatus Tear Clinical Trials

Novel Treatment for Rotator Cuff Tears

Start date: November 7, 2022
Phase: N/A
Study type: Interventional

The focus of this study is to examine changes in pain scores, strength, and range of motion over time following an ultrasonic tenotomy on a partial tear (<50%) of the supraspinatus tendon of the rotator cuff.

NCT ID: NCT05335785 Enrolling by invitation - Supraspinatus Tear Clinical Trials

Efficacy of High Intensity Lazer Therapy in Partial Supraspinatus Tear

Start date: December 2, 2020
Phase: N/A
Study type: Interventional

Rotatorcuff lesions constitute 10% of the causes of shoulder pain. Supraspinatus tear is one of the common rotatorcuff lesions. It affects the quality of life negatively and causes loss of range of motion and muscle strength. It can be seen due to traumatic or degenerative causes. Its incidence increases with advanced age. While the incidence was reported as 4% in the population aged 40-60 years, this rate was reported to be 17-50% in the group over the age of 60 and 80% in the group over the age of 80. Radiologically, classification is made as partial or full-thickness tears. Rotatorcuff tears can be treated conservatively or surgically. Although the risk of post-surgical rupture is reduced with new methods, the lack of desired tendon healing has led to the search for alternative applications such as biological augmentation and high-intensity laser. The aim of this study is to reveal the effectiveness of high-intensity laser therapy in patients with partial supraspinatus tear.

NCT ID: NCT04670302 Recruiting - Supraspinatus Tear Clinical Trials

Mesenchymal Stem Cells and Amniotic Membrane Composite for Supraspinatus Tendon Repair Augmentation

Start date: October 17, 2019
Phase: N/A
Study type: Interventional

This is a non-randomized clinical trial conducted in a single tertiary hospital which investigates the efficacy of allogeneic adipose-derived mesenchymal stem cells and human amniotic membrane (AAdMSC-HAM) composite for supraspinatus tendon repair augmentation

NCT ID: NCT04444076 Active, not recruiting - Supraspinatus Tear Clinical Trials

Clinical Trial on the Effect of REGENETEN Bioinductive Implant in the Supraspinatus Tendon Repair.

MALLAMANGUITO
Start date: June 17, 2020
Phase: N/A
Study type: Interventional

This study aims a determine the effect that the addition of REGENETEN Bioinductive Implant has on Supraspinatus Tendon Repair. 120 patients will be included in this prospective, randomized, parallel group study.

NCT ID: NCT03942679 Completed - Supraspinatus Tear Clinical Trials

Platelet Rich Plasma and Supraspinatus Tear

Start date: June 1, 2019
Phase: N/A
Study type: Interventional

Rheumatology and Rehabilitation Department, Mansoura University Hospital. Forty patients with chronic partial supraspinatus tears will be included in the study. The diagnosis of the supraspinatus tear will be made by ultrasound examination

NCT ID: NCT03084068 Completed - Shoulder Injury Clinical Trials

Use of Human Dehydrated Umbilical Cord Allograft in Supraspinatus Tendon Repair

Start date: February 1, 2017
Phase: N/A
Study type: Interventional

To determine the effectiveness of human dehydrated umbilical cord allograft in standard open rotator cuff repair as assessed by the American Shoulder and Elbow Surgeons (ASES) score 12 months post-op.

NCT ID: NCT01414764 Enrolling by invitation - Supraspinatus Tear Clinical Trials

Does Autologous Conditioned Plasma Enhance Rotator Cuff Tendon Healing After Surgery?

Start date: May 2011
Phase: Phase 3
Study type: Interventional

The aim of this study is to establish if the application of autologous conditioned plasma (ACP), also described as platelet rich plasma (PRP), to the site of supraspinatus tendon repair beginning within two weeks of surgery, can improve patient outcomes over the course of 12 months. These outcomes will be measured by post-surgical pain and function scores, shoulder strength and range of motion (ROM), and radiological parameters of tendon healing. Outcome measures will be compared to a control group of patients receiving placebo injections following surgery (saline plus local anaesthetic). This study is significant for being the first double blind randomised control trial, using two PRP injections to examine the efficacy of a PRP preparation following surgical repair of supraspinatus tendon. The objective is to prolong and enhance the tendon healing response initiated by surgery. The research hypothesis is that enhanced tendon healing following the PRP injections will lead to more rapid rehabilitation and lower rates of re-rupture of the repaired tendon compared to the control group.